Browse the world's most comprehensive database of hedge fund investor letters, sorted by recent quarter. Access primary source research from leading institutional managers.
Buyside Digest is not affiliated with, and does not endorse, Fidelity Growth Strategies Fund. This analysis is provided for institutional research purposes only and is not investment advice.
Fund Returns
QTD-2.39%
Annualized+11.26%
Digest Analysis
Quick Take
"Fidelity Growth Strategies Fund outperformed its mid-cap growth benchmark through strong security selection, particularly benefiting from AI infrastructure plays like Vistra and medical device growth stories."
Executive Summary
Fidelity Growth Strategies Fund returned -2.39% in Q2 2024, modestly outpacing its Russell Midcap Growth Index benchmark's -3.21% return. The fund's core thesis centers on owning high-quality companies with persistent growth and positive free cash flow at reasonable prices. Security selection drove outperformance, particularly in consumer discretionary, information technology, and health care. Key contributors included utility Vistra, which benefits from AI data center buildout, and medical device maker Insulet with strong insulin pump demand. Detractors included managed care firm Molina Healthcare, hurt by industry-wide cost pressures. The fund maintains significant overweights in industrials, believing many companies will benefit from AI infrastructure investment. Manager Shilpa Mehra is watching for AI-related strength to expand beyond industrials and utilities across the mid-cap universe. The portfolio emphasizes companies with net cash balance sheets for stability during volatile periods. Looking forward, the fund remains highly selective, focusing on free cash flow generation and reasonable valuations while anticipating continued market volatility.
Unlock Full Institutional Analysis
Sign in or create a free account to unlock full commentary, extracted equity pitches, and direct outbound manager source links with your 3 quarterly credits.
Algorithmic conviction, macroeconomic posture, and risk appetite signals extracted from this quarterly letter with qualitative explanations.
Signal Matrix
Market Conviction
68%
CautiousHigh
Moderate (68%)
The fund demonstrates moderate-high conviction through concentrated sector overweights (26.4% industrials vs 19.7% benchmark), specific position sizing decisions like reducing Insulet to manage size, and clear thesis around AI infrastructure beneficiaries. However, the diversified 113-holding portfolio and hedged language around selectivity prevents a higher score.
Growth Outlook
25%
BearishBullish
Bearish (25%)
The manager acknowledges market challenges with narrow breadth and concentration in mega-cap tech stocks, but sees selective opportunities in AI infrastructure buildout and mid-cap expansion potential. Mixed outlook with cautious optimism about specific themes.
Risk Appetite
15%
DefensiveAggressive
Defensive (15%)
The fund added to consumer discretionary positioning and maintains overweight industrials exposure, but emphasizes being highly selective and focusing on companies with net cash balance sheets for stability. Moderate risk appetite with defensive elements.
Capital Deployment
25%
De-riskingDeploying
De-risking (25%)
The fund added new positions like Ulta Beauty and increased consumer discretionary from underweight to overweight, indicating selective deployment. However, they also reduced some positions like Insulet and overall health care exposure, suggesting rotation rather than aggressive net deployment.
Forward Guidance
10%
CautiousExpansionary
Cautious (10%)
Manager states they are being highly selective while trying to find good entry points, anticipating more market volatility. Language suggests cautious deployment rather than aggressive positioning changes.
Language Signal
20%
BearishBullish
Bearish (20%)
Balanced language with mentions of opportunities in AI infrastructure and data centers, but also acknowledges challenges like narrow market breadth and volatility. Slightly more constructive than bearish overall.
Perceived Risk
45%
Low RiskElevated
Moderate Risk (45%)
Manager acknowledges market volatility, narrow breadth concerns, and industry-specific challenges like managed care cost pressures. Anticipates more market volatility ahead but doesn't express systemic risk concerns. Moderate risk awareness with standard market cautions.
Opportunity Density
55%
ScarceAbundant
Selective (55%)
Manager sees selective opportunities in AI infrastructure and data centers, and found attractive entry points in consumer discretionary names like Ulta Beauty. However, emphasizes being highly selective and finding good entry points, suggesting opportunities require careful screening rather than being abundant.
Time Horizon
70%
Short-TermLong-Term
Decade+ (70%)
The fund focuses on companies generating free cash flow and emphasizes owning high-quality companies that can outperform over time. Investment process is described as bottom-up fundamental analysis with multi-year themes like AI infrastructure buildout, indicating a medium to long-term investment horizon.